Abstract:Background: Circular RNAs (circRNAs), a novel type of ncRNAs, are covalently linked to make up circular configuration via a loop structure. Accumulating evidence indicate that circRNAs are potential biomarkers and key regulators in the development and progression of tumors. However, the precise role of circRNAs in renal cell carcinoma (RCC) remains unknown.Methods: Though circRNA high-throughput sequencing from RCC cell lines, we determined circRNA TLK1 (circTLK1 ) as a novel candidate circRNA derived from TLK1 gene. Quantitative real-time PCR (qRT-PCR) was performed to detect the expression levels of mRNAs, circRNAs and miRNAs in RCC tissues and cells. Loss-of function experiments were executed to detect the biological roles of circTLK1 on the phenotypes of RCC cells in vitro and in vivo. RNA-FISH, RNA-pull down, dual-luciferase reporter, western blot and immunohistochemistry assay were used to investigate the molecular mechanisms underlying the functions of circTLK1.Findings: CircTLK1 is overexpressed in RCC and positively corelated with distant metastasis and unfavorable prognosis. Silence of circTLK1 significantly inhibits the proliferation, migration and invasion of RCC cells in vitro and in vivo. Mechanistically, circTLK1 is mainly distributed in the cytoplasm and positively regulates CBX4 expression by sponging miR-136-5p. In addition, forced expression of CBX4 reverses the phenotypes inhibition of RCC cells induced by circTLK1 suppression. Moreover, CBX4 expression is positively corelated with VEGF expression in renal cancer tissues. Knockdown of CBX4 significantly inhibited VEGF expression in RCC cells.Interpretation: Collectively, our findings demonstrate that circTLK1 plays a critical role in RCC progression by sponging miR-136-5p to increase CBX4 expression. CircTLK1 may act as a diagnostic biomarker and therapeutic target for RCC.Funding Statement: This study was supported by grants from Guangdong Key Laboratories (2017B030314074) and the Shenzhen Project of Science and Technology (JCYJ20170413100245260).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: This study was approved by the ethical committee of Perking University Shenzhen Hospital. All patients agreed that their samples could be applied to the experimental studies and paper presentations.In vivo assay was approved by the animal management committee of Perking University Shenzhen Hospital, and all experimental procedures and animal care were in line with the institutional ethics guidelines for animal experiments.

Circ_0008717 Promotes Renal Cell Carcinoma Progression by Upregulating FBXO17 Via Targeting Mir-217

CircCTNNA1 Acts As a Cerna for Mir-363-3p to Facilitate the Progression of Colorectal Cancer by Promoting CXCL5 Expression

Circular RNA Microarray Expression Profile and Potential Function of Circ0005875 in Clear Cell Renal Cell Carcinoma.

Circular RNA Circrims1 Acts As a Sponge of Mir-433-3p to Promote Bladder Cancer Progression by Regulating CCAR1 Expression.

CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma

Circ_0101692 knockdown retards the development of clear cell renal cell carcinoma through miR-384/FN1 pathway

Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p

Circ_0020123 Increases ZFX Expression to Facilitate Non-Small Cell Lung Cancer Progression by Sponging miR-142-3p

CircTLK1 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma Through Sponging Mir-136-5p and Regulating CBX4 Expression

Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression Through Mirna-411–Dependent CDH2 Inhibition

Circ_0075829 Facilitates the Progression of Pancreatic Carcinoma by Sponging Mir-1287-5p and Activating LAMTOR3 Signalling.

Circ_0001786 facilitates gefitinib resistance and malignant progression in non-small cell lung cancer via miR-34b-5p/SRSF1

Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression Through Mir-1184/Rap2b Axis

Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells

Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p

Circ_000829 Plays an Anticancer Role in Renal Cell Carcinoma by Suppressing SRSF1-Mediated Alternative Splicing of SLC39A14

CircTLK1 Promotes the Proliferation and Metastasis of Renal Cell Carcinoma by Sponging Mir-136-5p.

Circ_0000527 promotes the progression of retinoblastoma by regulating miR-646/LRP6 axis

Circ_0051079 Functions As an Oncogenic Regulator in Osteosarcoma by Leading to MAFB Expression Upregulation by Competitively Interacting with Mir-1286

Hsa_circ_0017956 Acts as miR-758-3p Sponge to Facilitate the Progression of Non-small-Cell Lung Cancer by Regulating FOXP4 Expression

Circ_0001667 Accelerates Breast Cancer Proliferation and Angiogenesis Through Regulating CXCL10 Expression by Sponging Mir‐6838‐5p